Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Trained dogs detect thyroid cancer with great accuracy
Dog nose
“What we have done, no one has attempted to do. We have taken the next step by asking the dog to tell us whether or not cancer exists before the medical diagnostic system does."

Finding described as a 'tremendous advance'

Scent-trained dogs can sniff-out thyroid cancer with almost 90 per cent accuracy, according to research by the University of Arkansas for Medical Sciences (UAMS).

Presenting their findings at the Endocrine Society's ENDO 2015 conference earlier this month, the researchers said that having a technique with which to detect thyroid cancer to such a high degree of certainty would be a 'tremendous advance'.

They hope that the finding will lead to cost savings in diagnoses and the prevention of unnecessary surgeries.

It is also hoped that the method could be transported to under-served areas where traditional methods of biopsy and ultrasound are unavailable.

Furthermore, the researchers believe the training could potentially be used in diagnoses of other cancers such as ovarian, breast, kidney, bladder and prostate.

Detecting a diagnosis thyroid cancer can be difficult, because it's often looking for a very small number of occurrences in a very large background of benign nodules. It is also very difficult to say that a patient is cancer free after surgery.

The study took dogs already trained for scent detection and imprinted them with fresh tissue taken from patients diagnoses with papillary thyroid cancer.

The dogs were then presented with urine samples from patients, some with thyroid cancer and some with benign modules, and asked to indicate whether each sample had thyroid cancer or not.

Their results were compared to a surgical pathology diagnosis and matched in 30 out of 34 cases - or 88.2 per cent accuracy.

Commenting on the study, lead author Dr Arny Ferrano said: “What we have done, no one has attempted to do. We have taken the next step by asking the dog to tell us whether or not cancer exists before the medical diagnostic system does. We wanted to see, can the doctor utilise the dog to help diagnose cancer?"

So far, the results have led the researchers believe the answer to be 'yes'.

“We’ve all looked at it from a skeptical, scientific standpoint, but the data just keeps leading us to the fact that this has remarkable clinical potential,” said Ferrano.

Up to now, the team have used what are known as 'general source' dogs, or strays that have been trained in scent detection methods. They now plan to work with researchers at Auburn University's Canine Performance Sciences programme to teach and imprint dogs that have been specifically bred for medical detection. 

Become a member or log in to add this story to your CPD history

NOAH board elected

News Story 1
 NOAH has elected its board team, as part of its annual general meeting.

Ned Flaxman, general manager at Norbrook Laboratories Ltd, retains his position as chair, which he has held since June 2023.

Caitrina Oakes (Vetoquinol) remains past chair, and Matthew Frost (Elanco) remains treasurer.

Andrew Buglass (Eco Animal Health Ltd), Oya Canbas (Zoetis) and Charlotte Covell (Virbac) are newly elected vice-chairs. Meanwhile Roy Geary (Ceva) and John Toole (Beaphar) join the NOAH Board of Management.

Dawn Howard, NOAH chief executive, said: "I congratulate all the officers and board members who have been elected or re-elected today.

"I look forward to working together to ensure that NOAH continues to deliver at the highest standard for its members." 

Click here for more...
News Shorts
Series two of SCOPS podcast launched

The Sustainable Control of Parasites in Sheep (SCOPS) Group has launched the second series of its podcast.

The series will comprise four episodes, with topics including the sustainable use of parasite treatments, effective quarantining, administrating a mid/late season dose, and tackling resistance to multiple groups of anthelmintic.

Kevin Harrison, Gloucestershire sheep farmer and SCOPS chair, said: "The podcast is suitable for sheep farmers, vets and advisers, so please subscribe and spread the word if you enjoy the content.

"All episodes from series one are still available online, as well as the new episodes being added."

The podcast is available on the SCOPS website and other podcast platforms.